Skip to content

Clinical trials

Completed Leukemia, Erythroblastic, Acute trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Erythroblastic, Acute Status: Completed Country / region: United States Clear all

100 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20012
20026
20032
200412
200510
20067
20075
20087
20093
20104
20115
20121
20136
20142
20151

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed100

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)34
Case Comprehensive Cancer Center10
Fred Hutchinson Cancer Center6
SWOG Cancer Research Network5
Roswell Park Cancer Institute4
Eastern Cooperative Oncology Group3
Memorial Sloan Kettering Cancer Center3
Northwestern University3
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3
Alliance for Clinical Trials in Oncology2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Erythroblastic, Acute100
Leukemia, Myeloid, Acute98
Leukemia, Megakaryoblastic, Acute95
Leukemia, Monocytic, Acute91
Leukemia, Myelomonocytic, Acute89
Congenital Abnormalities67
Leukemia47
Leukemia, Basophilic, Acute30
Leukemia, Eosinophilic, Acute30
Precursor Cell Lymphoblastic Leukemia-Lymphoma29

Trials

Showing 1 to 25 of 100. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.